InMode Projects Steady Q1 2026 Revenue, Reiterates Full-Year Guidance
Event summary
- InMode expects Q1 2026 revenue between $81.5M and $81.7M, up from $78.3M in Q1 2025.
- Non-GAAP gross margin projected at 75-76%, consistent with prior quarters.
- Full-year 2026 revenue guidance reaffirmed at $365M-$375M.
- Earnings call scheduled for May 6, 2026, with CEO Moshe Mizrahy, CFO Yair Malca, and CTO Dr. Michael Kreindel.
The big picture
InMode's steady revenue projections reflect its strong position in the minimally invasive medical device market. The company's focus on RF technology continues to drive growth across multiple medical specialties, though it faces increasing competition from both established players and emerging startups. The reaffirmation of full-year guidance suggests confidence in its operational execution and market demand.
What we're watching
- Revenue Growth
- Whether InMode can sustain its projected 4-5% year-over-year revenue growth amid competitive pressures in the medical device sector.
- Margin Stability
- How the company maintains its high gross margins in a cost-sensitive healthcare environment.
- Market Expansion
- The pace at which InMode expands its product portfolio across plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology.
Related topics